• <b id="pcv1a"><em id="pcv1a"><strong id="pcv1a"></strong></em></b>
  • <b id="pcv1a"><address id="pcv1a"><strong id="pcv1a"></strong></address></b>
    <source id="pcv1a"></source>

      <u id="pcv1a"></u>
    1. 迪沙藥業連續8年蟬聯中國醫藥工業百強

      發布時間:

      2022-11-16

      作者:


      由中國醫藥工業信息中心主辦的2018年(第35屆)全國醫藥工業信息年會在上海盛大開幕,大會隆重發布了備受行業關注的2017年度中國醫藥工業百強企業榜單,迪沙藥業再次榮登百強榜,連續8年蟬聯中國醫藥工業百強。
       
      根據中國醫藥工業信息中心的統計和分析,2017年度百強榜上榜企業延續了一貫的強勁增長動力,以主營業務收入10.2%的增速突破7,500億大關,雖然增速較上年同期下降0.9個百分點,但增長趨勢仍基本保持平穩。值得注意的是,百強榜門檻也由去年的24.4億元提升至25.6億元,小幅提升5%。在百強企業的龍頭帶動作用下,醫藥產業正逐步邁向規模經濟。
       
      迪沙藥業始建于1993年,位于譽滿全球的生態宜居之城——威海,歷經20余載風雨兼程、披荊斬棘,漸已發展成為傳奇威海、屹立齊魯、馳名中國、走向世界的制藥強企。集團是產學研相結合、科工貿一體化的國家重點高新技術企業,經過20多年發展,現已形成制劑、綠色高科技原料藥、海洋生物健康產業3大業務板塊,建成西藥制劑、原料藥、中藥、海洋生物新材料、海洋生物健康產品五大生產基地。2017年實現銷售收入36億元,連續8年入選中國醫藥工業百強企業。 
      迪沙藥業圖
      迪沙藥業集團有限公司培養基供應商:青島日水生物

      China Pharmaceutical Industry Information Center (CMIC) sponsored the opening of the National Medicinal Industry Information Annual Meeting in Shanghai in 2018. The meeting solemnly released the list of the top 100 enterprises in China's pharmaceutical industry in 2017, which attracted the attention of the industry. Disha Pharmaceutical Industry was once again ranked the top 100 enterprises in China's pharmaceutical industry for eight consecutive years.
      According to the statistics and analysis of the China Pharmaceutical Industry Information Center, the enterprises listed on the Top 100 list in 2017 continued their strong growth momentum, breaking through 750 billion yuan mark with the growth rate of 10.2% of the main business income. Although the growth rate decreased by 0.9 percentage points compared with the same period last year, the growth trend remained basically stable. It is worth noting that the top 100 threshold also increased from 2 billion 440 million yuan last year to 2 billion 560 million yuan, a slight increase of 5%. Under the leading role of top 100 enterprises, the pharmaceutical industry is gradually moving towards scale economy.
      Disha Pharmaceutical Co., Ltd. was founded in 1993. It is located in Weihai, an ecologically livable city with a global reputation. The group is a national key high-tech enterprise which integrates production, learning and research, science, industry and trade. After more than 20 years of development, it has formed three major business sectors: preparations, green high-tech raw materials, marine biological health industry, and has built five major students: western medicine preparations, raw materials, traditional Chinese medicine, new marine biological materials and marine biological health products. Production base. In 2017, the sales revenue reached 3 billion 600 million yuan and was selected into top 100 enterprises in China's pharmaceutical industry for 8 consecutive years.